AzTrials
AzTrials

Psychological DisorderMosaiqueNCT05385666

Collaborative Mental Health Care Model: an Evaluation of the Implementation of a Pilot in Four Primary Care Organization

A study testing collaborative cares in people with Psychological Disorder, run by Dr Nadia YOUNES at 3 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Frequent mental disorders (anxiety or mood disorders), an important part of primary care patient care, remain insufficiently detected and treated. Improving their care requires better coordination between general practice and specialized care. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Psychological Disorder
What is being tested?
collaborative cares
Could I receive a placebo?
No, everyone receives an active treatment
How many people
410 participants
Where
3 sitesFrance
Study dates
13 Jul 2022to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • healthcare professionals involved in the collaborative care system
  • patients who have been referred for collaborative care by their family physician

Who cannot join

  • patient refusal to participate in research
  • adults protected by law

Trial locations and contacts

3 sites in 1 country.

France3 sites
  • Maison de Santé Pluridisciplinaire

    Chevreuse, France, 78460

  • Maison de Santé Pluridisciplinaire

    Les Mureaux, France, 78130

  • Cabinet Médical Versailles

    Versailles, France, 78000

Other trials in France

About this study

Official title: Collaborative Mental Health Care Model: an Evaluation of the Implementation of a Pilot in Four Health Homes

Frequent mental disorders (anxiety or mood disorders), an important part of primary care patient care, remain insufficiently detected and treated. Improving their care requires better coordination between general practice and specialized care. The collaborative care model developed in Washington State with the introduction of a care manager is recognized. About 100 randomized controlled trials have established its effectiveness and efficiency, in terms of improving the progression of disorders (remission rate), adherence, quality of life, professional and patient satisfaction, and cost savings. However, the possibility of implementation of these validated care remains to be explored. A dozen collaborative care implementation studies exist, all conducted in the USA and not having considered all the dimensions of the indicators of penetration, acceptability/adoption, feasibility, fidelity and cost. A first implementation in France is implemented since September 2021 in the Yvelines department on four sites of different size, organization and environments: the multi-professional health centers (MSP) of Mureaux and Celle St Cloud, the Chevreuse medical house and MG in isolated practice in Versailles.

The main objective of the research project is to evaluate the first implementation in France of collaborative care for frequent psychic disorders according to the indicators of penetration, acceptability/adoption, fidelity, relevance, feasibility and cost.

Being tested
collaborative cares
Medical subject headings
Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • collaborative caresOther

    coordinate care between city medicine and specialized psychiatric care to improve the management of common mental disorders

Study groups in NCT05385666
Study groupRoleWhat they receive
group experimentalExperimentalNot described
Receives: Other: collaborative cares

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. to evaluate the first implementation in France of collaborative care for frequent psychic disorders

    numbers of patients and medical caregivers who participate in collaborative care

    Measured: 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2022
  2. Study start13 Jul 2022
  3. Primary completion31 May 2025
  4. Study completion31 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
410 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05385666
Sponsor's protocol ID
P21/10_mosaïque
Acronym
Mosaique
Status last verified
Jun 2026
First submitted
12 May 2022
Last updated
25 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Younes N, Touitou-Burckard E, Ros E, Clerc P, Passerieux C, Mousques J, Gandre C. First implementation of a collaborative care model for common mental disorders in primary care in France: fidelity of care manager intervention matters. BMC Health Serv Res. 2026 Apr 22;26(1):800. doi: 10.1186/s12913-026-14568-1.

    PubMed 42021326

Questions about this trial

What is this clinical trial studying?

A study testing collaborative cares in people with Psychological Disorder, run by Dr Nadia YOUNES at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

to evaluate the first implementation in France of collaborative care for frequent psychic disorders (time frame: 36 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05385666, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in